Monthly Archives: January 2018

 2017 Oncology Highlights

    Btobioinnovation.com     Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com     “2017 Oncology Development Review” from Bruno Pagliari   Bruno Pagliara, principal of On-Kos Pharma Consulting in Milan, Italy, publishes regularly reviews on the status of worldwide oncology clinical portfolio. You will find herewith some of the highlights of his most recent report […]

read more

China FDA Releases Guidance on Acceptance of Foreign Medical Device Study Data

  January 19, 2018   Practices: China Life Sciences   On January 10, 2018, the China Food and Drug Administration (“CFDA”) announced the implementation of the Technical Guidelines Governing Acceptance of Medical Device Clinical Data from Foreign Studies (the “2017 Guidelines”).   The long-awaited 2017 Guidelines explain the principles, acceptance criteria, technical requirements and considerations for accepting […]

read more

Screening for breast and ovarian cancer mutations can be cost effective

Research backs blanket screening for breast, ovarian cancer mutations   18th January 2018 by Selina McKee from PharmaTimes   Research led by Queen Mary University of London has concluded that whole-population testing for mutations linked with a higher risk of breast and ovarian cancer is cost-effective. Screening the entire population for such genetic mutations instead of just […]

read more

“Firsts” Drug Approvals by the US FDA

Many “Firsts” for CDER’s 2017 Drug Approvals Reflect Innovation and Enhanced Patient Care   Posted on January 10, 2018 by FDA Voice   By: Janet Woodcock, M.D.     In 2017, FDA’s Center for Drug Evaluation and Research (CDER) approved many new drugs never before marketed in the United States, known as “novel” drugs, to help improve people’s […]

read more

More on Alzheimer’s Disease Treatment

  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation,   jcm@btobioinnovation.com         More on Alzheimer’s Disease Treatment     A recent paper entitled “Why so many clinical trials of therapies for Alzheimer’s disease fail?” published in the November 25, 2017 issue of The Lancet comes to a striking conclusion.   Roy Anderson et al from […]

read more

Btobioinnovation wishes you a happy New Year 2018

Btobioinnovation wishes you a happy New Year 2018 Full of success in your Research & Business Development

read more